Is Cemtrex, Inc. overvalued or undervalued?

As of 18 February 2022, the valuation grade for Cemtrex, Inc. has moved from fair to risky, indicating a deteriorating outlook. The company is overvalued based on its current financial metrics, with a Price to Book Value of 0.44, an EV to Sales ratio of 0.26, and a troubling ROE of -58.21%. Compared to peers, Cemtrex's EV to EBITDA stands at 19.20, while Laser Photonics Corp. and Soluna Holdings, Inc. show significantly lower ratios of -5.6572 and -1.9614, respectively, highlighting its relative overvaluation.
The stock has performed poorly against the S&P 500, with a year-to-date return of -77.28% compared to the index's positive return of 12.22%. This stark contrast reinforces the notion that Cemtrex is not only struggling operationally but is also overvalued in the current market context.